Significant erythroid megaloblastic changes in patients treated with allopurinol during maintenance chemotherapy for acute lymphoblastic leukemia

Pediatr Blood Cancer. 2023 Nov;70(11):e30631. doi: 10.1002/pbc.30631. Epub 2023 Aug 14.

Authors

Connor Tompkins¹, Julienne Brackett^{1

2}, Austin J Stuckert^{1

2}, M Tarek Elghetany^{1

2}, Eric S Schafer^{1

2}

Affiliations

¹ Baylor College of Medicine, Houston, Texas, USA.
² Texas Children's Cancer Center, Houston, Texas, USA.

PMID: 37580904
DOI: 10.1002/pbc.30631

No abstract available

Publication types

Letter

MeSH terms

Allopurinol* / therapeutic use
Antimetabolites, Antineoplastic / therapeutic use
Humans
Maintenance Chemotherapy
Precursor Cell Lymphoblastic Leukemia-Lymphoma* / drug therapy

Substances

Allopurinol
Antimetabolites, Antineoplastic